Disciplined Growth Investors Inc. MN increased its position in Plexus Corp. (NASDAQ:PLXS – Free Report) by 0.3% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,109,047 shares of the technology company’s stock after acquiring an additional 7,245 shares during the period. Plexus makes up 4.1% of Disciplined Growth Investors Inc. MN’s portfolio, making the stock its 4th biggest position. Disciplined Growth Investors Inc. MN owned approximately 0.08% of Plexus worth $217,611,000 at the end of the most recent quarter.
Other hedge funds have also recently bought and sold shares of the company. UniSuper Management Pty Ltd bought a new position in shares of Plexus in the first quarter worth $515,000. Norges Bank acquired a new position in Plexus during the 4th quarter valued at about $19,533,000. Quantbot Technologies LP bought a new stake in shares of Plexus during the 1st quarter worth about $533,000. Fiduciary Management Inc. WI lifted its stake in shares of Plexus by 3.8% in the 4th quarter. Fiduciary Management Inc. WI now owns 1,226,917 shares of the technology company’s stock worth $132,667,000 after acquiring an additional 44,398 shares during the period. Finally, Vanguard Group Inc. boosted its holdings in shares of Plexus by 2.2% in the first quarter. Vanguard Group Inc. now owns 3,515,866 shares of the technology company’s stock valued at $333,374,000 after acquiring an additional 74,988 shares in the last quarter. 94.45% of the stock is currently owned by institutional investors.
Plexus Stock Up 0.3 %
PLXS opened at $136.44 on Friday. The company has a market capitalization of $3.72 billion, a PE ratio of 37.69 and a beta of 0.89. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.47 and a quick ratio of 0.64. Plexus Corp. has a fifty-two week low of $87.21 and a fifty-two week high of $138.20. The business has a 50-day moving average of $124.65 and a 200-day moving average of $110.26.
Insider Activity
In related news, Director Karen Marie Rapp sold 500 shares of the stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $128.02, for a total transaction of $64,010.00. Following the completion of the sale, the director now owns 9,586 shares in the company, valued at approximately $1,227,199.72. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In related news, insider Steven J. Frisch sold 6,565 shares of the company’s stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $128.11, for a total transaction of $841,042.15. Following the completion of the transaction, the insider now directly owns 36,118 shares in the company, valued at approximately $4,627,076.98. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Karen Marie Rapp sold 500 shares of the stock in a transaction on Friday, August 30th. The shares were sold at an average price of $128.02, for a total transaction of $64,010.00. Following the completion of the sale, the director now directly owns 9,586 shares of the company’s stock, valued at $1,227,199.72. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 21,769 shares of company stock valued at $2,731,834. 2.39% of the stock is owned by insiders.
Wall Street Analysts Forecast Growth
A number of research firms have weighed in on PLXS. Needham & Company LLC upped their target price on Plexus from $114.00 to $144.00 and gave the stock a “buy” rating in a research report on Friday, July 26th. Benchmark upped their price objective on Plexus from $120.00 to $145.00 and gave the company a “buy” rating in a report on Monday, July 29th. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat, Plexus currently has a consensus rating of “Hold” and an average target price of $124.00.
View Our Latest Research Report on PLXS
Plexus Company Profile
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Read More
- Five stocks we like better than Plexus
- What Are the FAANG Stocks and Are They Good Investments?
- Simon Property REIT: A Safe Bet for Growth and Steady Dividends
- What Does Downgrade Mean in Investing?
- CarMax’s Impressive Rally: What Investors Should Watch Next
- Best Aerospace Stocks Investing
- MarketBeat Week in Review – 9/23 – 9/27
Want to see what other hedge funds are holding PLXS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Plexus Corp. (NASDAQ:PLXS – Free Report).
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.